Dr. Anthony C. Nicholls
Dr. Anthony C. Nicholls . Dr. Nicholls has served as a director since 2005.
Dr. Nicholls is an independent consultant with over 30 years' experience in medical devices and diagnostics research.
has lectured in 45 countries of the world on subjects varying from the rapid diagnosis of Sepsis, Tuberculosis and Aids to vaccine production, environmental responsibility and entrepreneurship.
He co-founded FAS Medical Ltd. in 1992, and as CEO, raised (CDN) $6 million, achieved a listing on CDNX and established sales of the company's products in 21 countries.
He was employed as CEO of FAS Medical Ltd. from 1992 to 2003.
Previously he was CEO of Trinity Biotech PLC and oversaw a successful IPO on NASDAQ.
Earlier, Dr. Nicholls held senior management posts with Cambridge Biotech Corp. (Exec. VP), Biotech Research Labs Inc. (Pres. & COO), Fisher Scientific (Senior VP. & Gen.
Manager), Ciba Corning Medical (Director, New Technology Development) and Flow General (International Scientific Director).
Dr. Nicholls' academic career included seven years as Head of Microbiology and Immunology at the Midhurst Medical Research Institute in Sussex, England, where he published numerous papers on tuberculosis, pneumonia and sepsis.
Dr. Nicholls is a graduate of the University of Birmingham School of Medical Sciences and has a Ph.D. in Immunology.